Central Anticholinergic Syndrome Following Excessive Mydriatic Use in an Eight-Year-Old Patient

dc.authorscopusid34880218200en_US
dc.authorscopusid20733555900en_US
dc.authorscopusid57765899700en_US
dc.authorscopusid27367493800en_US
dc.authorwosidGRX-5259-2022en_US
dc.authorwosidABF-5836-2021en_US
dc.authorwosid-en_US
dc.authorwosidHKV-4794-2023en_US
dc.contributor.authorKaymaz, Nazan
dc.contributor.authorUzun, Mehmet Erdem
dc.contributor.authorBattal, Fatih
dc.contributor.authorGüzel, Yusuf
dc.contributor.authorAylanç, Hakan
dc.date.accessioned2025-02-07T07:58:07Z
dc.date.available2025-02-07T07:58:07Z
dc.date.issued2021en_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractCyclopentolate hydrochloride, belonging to a class of drugs known as anticholinergics, is an ophthalmic solution frequently used in ophthalmology clinics because of its cycloplegic and mydriatic effects in both refractions as well as fundus examinations. After application, the maximum cycloplegic effect begins approximately after 30-60 min, which can further continue up to 24 h. Due to a dose-dependent relationship, cyclopentolate hydrochloride’s side effects can be observed both in an ocular and systemic manner which may occur if solutions more than 0.5% concentration are used. Herein, we report central anticholinergic syndrome due to the administration of excessive amounts of cyclopentolate hydrochloride in a child.en_US
dc.identifier.citationKaymaz, N., Uzun, M. E., Battal, F., Güzel, Y., & Aylanç, H. (2021). Central Anticholinergic Syndrome Following Excessive Mydriatic Use in an Eight-Year-Old Patient. Trends in Pediatrics, 2(4), 170–172. https://doi.org/10.4274/TP.galenos.2021.96168en_US
dc.identifier.doi10.4274/TP.galenos.2021.96168en_US
dc.identifier.endpage172en_US
dc.identifier.issn2718-0085 / 2792-0429
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85162801821en_US
dc.identifier.scopusqualityQ4
dc.identifier.startpage170en_US
dc.identifier.trdizinid532815en_US
dc.identifier.urihttps://doi.org/10.4274/TP.galenos.2021.96168
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/532815
dc.identifier.urihttps://hdl.handle.net/20.500.12428/29575
dc.identifier.volume2en_US
dc.identifier.wosWOS:001209353500005en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.institutionauthorKaymaz, Nazan
dc.institutionauthorBattal, Fatih
dc.institutionauthorGüzel, Yusuf
dc.institutionauthorAylanç, Hakan
dc.institutionauthorid0000-0002-3962-4799
dc.institutionauthorid0000-0001-9040-7880
dc.institutionauthorid0000-0002-1241-3561
dc.institutionauthorid0000-0002-8907-3809
dc.language.isoengen_US
dc.publisherAydın Pediatric Societyen_US
dc.relation.ispartofTrends in Pediatricsen_US
dc.relation.publicationcategoryRaporen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectChilden_US
dc.subjectCyclopentolateen_US
dc.subjectDilatationen_US
dc.subjectMydriaticsen_US
dc.subjectOphthalmic solutionsen_US
dc.titleCentral Anticholinergic Syndrome Following Excessive Mydriatic Use in an Eight-Year-Old Patienten_US
dc.typereporten_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Fattih Battal_Report.pdf
Boyut:
150.22 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Case Report
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.21 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: